Clotrimazole And Betamethasone Dipropionate NDC 72189-182

NDC codes

FDA NDC Directory

Product NDC (as listed)72189-182Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72189-0182Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72189-182-15	72189018215	15 g in 1 TUBE (72189-182-15)Marketed from Feb 23, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clotrimazole And Betamethasone Dipropionate
Generic name (nonproprietary): clotrimazole and betamethasone dipropionate
Active ingredients: Clotrimazole — 10 mg/gBetamethasone dipropionate — .5 mg/g
Dosage form: Cream
Route: Topical
Labeler: Direct Rx
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202894
Marketing start: Feb 23, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Azoles (Chemical structure)Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 72189-182_2be953af-ba6f-e430-e063-6294a90a9a1aSPL ID 2be953af-ba6f-e430-e063-6294a90a9a1aSPL set ID bbf26437-c9b4-d8e6-e053-2a95a90a0062RxCUI 308714UNII G07GZ97H65, 826Y60901U
Pharmacologic class: Azole Antifungal; Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472189018215 followed by a unit qualifier and the quantity

Package 72189-0182-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 17, 2025.

Indications (excerpt from the label)

Clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum in patients 17 years and older.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202894

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202894
Product	Strength	Form · route	Labeler	Product NDC
Clotrimazole and Betamethasone Dipropionate	Clotrimazole 10 mg/g; Betamethasone dipropionate .5 mg/g	CreamTopical	Glenmark Pharmaceuticals Inc. USA	68462-298
Clotrimazole and Betamethasone Dipropionate	Clotrimazole 10 mg/g; Betamethasone dipropionate .5 mg/g	CreamTopical	Proficient Rx LP	71205-524
Clotrimazole and Betamethasone Dipropionate	Clotrimazole 10 mg/g; Betamethasone dipropionate .5 mg/g	CreamTopical	NuCare Pharmaceuticals,Inc.	68071-4134